Which hedge funds own MRNA? MODERNA INC, Q2 2026 13F holders
53 tracked hedge funds disclosed a position in MRNA (MODERNA INC) in their Q2 2026 13F filings, worth $2.8bn in total. The largest holder by portfolio weight is Theleme Partners LLP at 33.5% of its book. 12 opened a new position this quarter: Scientech Research LLC, AlphaGrep UK Ltd, TB Alternative Assets Ltd., Stevens Capital Management LP. 15 exited: Twin Tree Management, LP, Patton Fund Management, Inc., Twinbeech Capital LP.
- 53
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 12
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 15
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $18.1m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $107m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $2.8bn
- Combined value Sum of the holders' reported positions in the security.
- 4.3%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Twin Tree Management, LP | 1.3% | $6.4m |
| Patton Fund Management, Inc. | 0.8% | $4.5m |
| Twinbeech Capital LP | 0.2% | $1.8m |
| EntryPoint Capital, LLC | 0.1% | $351k |
| Voloridge Investment Management, LLC | 0.10% | $24.7m |
| Weiss Asset Management LP | 0.09% | $4.8m |
| Symmetry Investments LP | 0.07% | $305k |
| Renaissance Technologies LLC | 0.07% | $44.8m |
| Tudor Investment Corp ET AL | 0.04% | $7.3m |
| Point72 Asset Management, L.P. | 0.02% | $10.1m |
| ExodusPoint Capital Management, LP | 0.01% | $665k |
| Schonfeld Strategic Advisors LLC | 0.01% | $797k |
| Centiva Capital, LP | 0.01% | $139k |
| Capstone Investment Advisors, LLC | 0.0% | $292k |
| Elequin Capital, LP | 0.0% | $6.9k |
Ownership over time
Who discovered MRNA first? Beta
The run: Q3 2025 → Q3 2026, +646%
| Plustick Management LLC high conviction | Q1 2025 | 0.7% | +3.3 pts |
| Tobam | Q2 2025 | 0.7% | +1.9 pts |
| Telemark Asset Management, LLC high conviction | Q3 2025 | 1.2% | +0.8 pts |
| TB Alternative Assets Ltd. high conviction | Q1 2025 | 2.5% | −0.5 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.